(Q50648535)

17 March 2018

title

Seroprevalence of IgG antibodies to pertussis toxin in children and adolescents in Estonia. (English)

1 reference

17 March 2018

0 references

1 reference

1 reference

0 references

2

Marje Oona

1 reference

17 March 2018

6

Irja Lutsar

1 reference

17 March 2018

Piia Jõgi

1

1 reference

17 March 2018

Karolin Toompere

series ordinal

3

1 reference

17 March 2018

Sirje Leedo

series ordinal

4

1 reference

17 March 2018

Jevgenia Epstein

series ordinal

5

1 reference

17 March 2018

language of work or name

English

0 references

publication date

3 August 2014

1 reference

17 March 2018

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

17 March 2018

volume

32

1 reference

17 March 2018

issue

41

1 reference

17 March 2018

page(s)

5311-5315

1 reference

17 March 2018

How best to estimate the global burden of pertussis?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

Epidemiological characteristics of pertussis in Estonia, Lithuania, Romania, the Czech Republic, Poland and Turkey-1945 to 2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

Resurgence of pertussis in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

Epidemiology of pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

Accelerating control of pertussis in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

The seroepidemiology of Bordetella pertussis infection in Western Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

The utility of seroepidemiology for tracking trends in pertussis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

Seroprevalence of IgG antibodies to pertussis toxin in the Slovene population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

European Sero-Epidemiology Network: standardisation of the assay results for pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

The seroepidemiology of pertussis in Australia during an epidemic period.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

Prevalence of asymptomatic Bordetella pertussis and Bordetella parapertussis infections among school children in China as determined by pooled real-time PCR: a cross-sectional study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

Cumulative incidence of pertussis in an unvaccinated preschool cohort based on notifications, interview and serology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.066

10.1016/J.VACCINE.2014.07.066

7 January 2021

Identifiers

DOI

1 reference

17 March 2018

PubMed ID

25093282

1 reference

17 March 2018